According to Amedisys's latest financial reports the company's current EPS (TTM) is $3.46. In 2022 the company made an earnings per share (EPS) of $3.65 a decrease over its 2021 EPS that were of $6.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.46 | -5.21% |
2022 | $3.65 | -42.97% |
2021 | $6.40 | 13.68% |
2020 | $5.63 | 42.53% |
2019 | $3.95 | 8.22% |
2018 | $3.65 | 305.56% |
2017 | $0.90 | -19.64% |
2016 | $1.12 | -1118.18% |
2015 | -$0.11 | -128.21% |
2014 | $0.39 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() LHC Group LHCG | $2.06 | -40.46% | ๐บ๐ธ USA |
![]() National Healthcare
NHC | $1.22 | -64.74% | ๐บ๐ธ USA |
![]() Chemed CHE | $16.06 | 364.16% | ๐บ๐ธ USA |